Results 141 to 150 of about 6,623 (164)

Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series. [PDF]

Orphanet J Rare Dis
Suppressa P, Coppola C, Cocco V, O'Brien S.   +3 more
europepmc   +1 more source

Targeted NGS Revealed Pathogenic Mutation in a 13-Year-Old Patient with Homozygous Familial Hypercholesterolemia: A Case Report. [PDF]

Int J Mol Sci
Chamoieva AE, Mirmanova ZZ, Zhalbinova MR, Rakhimova SE, Daniyarov AZ, Kairov UY, Baigalkanova AI, Mukarov MA, Bekbossynova MS, Akilzhanova AR.   +9 more
europepmc   +1 more source

A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia. [PDF]

Sci Rep
Gu J, Epland M, Ma X, Park J, Sanchez RJ, Li Y.   +5 more
europepmc   +1 more source

Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review. [PDF]

Thromb J
Guan M, Wang H, Wang F, Liang S, Ling L, Wang B, Zhang L.   +6 more
europepmc   +1 more source

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.

JAMA Cardiol
Mulder JWCM, Tromp TR, Al-Khnifsawi M, Blom DJ, Chlebus K, Cuchel M, D'Erasmo L, Gallo A, Hovingh GK, Kim NT, Long J, Raal FJ, Schonck WAM, Soran H, Truong TH, Boersma E, Roeters van Lennep JE, Homozygous Familial Hypercholesterolemia International Clinical Collaborators.   +17 more
europepmc   +1 more source

Evinacumab for Homozygous Familial Hypercholesterolemia

New England Journal of Medicine, 2020
BACKGROUND: Homozygous familial hypercholesterolemia is characterized by premature cardiovascular disease caused by markedly elevated levels of low-density lipoprotein (LDL) cholesterol.
Frederick J Raäl, Laurens F Reeskamp, G Kees Hovingh   +2 more
exaly   +3 more sources

Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy

Circulation, 2011
Background— Homozygous familial hypercholesterolemia is an inherited disorder caused by mutations in both low-density lipoprotein receptor alleles, which results in extremely elevated plasma low-density lipoprotein cholesterol ...
Frederick J Raäl, Gillian J Pilcher, Vanessa R Panz   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia

Circulation, 2022
Mounica Vorla, Dipak Kalra
exaly